This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Med Diet Prevention Metabolic Syndrome Men Undergoing Androgen Deprivation Therapy Prostate Cancer

This study has been completed.
The Miriam Hospital
Information provided by (Responsible Party):
Dr Anthony Mega, Brown University Identifier:
First received: March 9, 2010
Last updated: July 21, 2015
Last verified: July 2015
The purpose of this study is to assess for changes in a patient's overall energy level and well-being (quality of life) after 8 weeks of dietary intervention.

Condition Intervention
Prostate Cancer Dietary Supplement: Olive Oil

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
Official Title: Eight Week Plant-based Mediterranean Diet as Prevention of Metabolic Syndrome in Men Undergoing Androgen Deprivation Therapy for Prostate Cancer: A BrUOG Pilot Study

Resource links provided by NLM:

Further study details as provided by Dr Anthony Mega, Brown University:

Primary Outcome Measures:
  • Changes in the Blood Chemistry (Fasting Triglycerides) After 8 Weeks of Following a Mediterranean Diet [ Time Frame: eight weeks ]
    Based on overall percentage change at baseline versus post diet

Secondary Outcome Measures:
  • To Assess Changes in the Body After 8 Weeks of Following a Mediterranean Diet [ Time Frame: 8 weeks ]
    Post diet waist circumference

Enrollment: 21
Study Start Date: February 2009
Study Completion Date: August 2012
Primary Completion Date: September 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Olive Oil
At least 3 tablespoons of olive oil each day
Dietary Supplement: Olive Oil
Minimum of 3 tablespoon of olive oil per day

Detailed Description:
Primary Objective: To assess for changes in the following measurements after 8 weeks of following a Mediterranean diet-- LDL, HDL, TG, FBS, creatinine, serum testosterone, triglycerides, serum insulin, CRP, 1bs, Waist circumference, blood pressure, body weight

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Histologically documented carcinoma of the prostate
  • On treatment with androgen deprivation therapy for at least 3 months
  • Required laboratory values:
  • Serum creatinine less than 2.5
  • Triglycerides <300
  • Fasting glucose < 126
  • Testosterone level <50

Exclusion Criteria:

  • No diabetes mellitus (Type 1 or 2)
  • No renal failure (Serum creatinine > 2.5)
  • No active cardiac disease -no history of myocardial infarction/stroke within the last 12 months, no recurrent unstable angina, uncontrolled/unstable arrhythmias, uncontrolled hypertension (systolic blood pressure >160, diastolic blood pressure >100)
  • No severe peripheral vascular disease
  • No commencement of lipid lowering agent within 8 weeks of enrollment the study or change in dose throughout the study
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01083771

United States, Rhode Island
Miriam Hospital
Providence, Rhode Island, United States, 02906
Sponsors and Collaborators
Dr Anthony Mega
The Miriam Hospital
Principal Investigator: Anthony Mega, MD The Miriam Hospital
  More Information

Responsible Party: Dr Anthony Mega, Principal Investigator, Brown University Identifier: NCT01083771     History of Changes
Other Study ID Numbers: BrUOG-MED/PROS-219
Study First Received: March 9, 2010
Results First Received: June 9, 2015
Last Updated: July 21, 2015

Additional relevant MeSH terms:
Prostatic Neoplasms
Metabolic Syndrome X
Genital Neoplasms, Male
Urogenital Neoplasms
Neoplasms by Site
Genital Diseases, Male
Prostatic Diseases
Insulin Resistance
Glucose Metabolism Disorders
Metabolic Diseases
Hormones, Hormone Substitutes, and Hormone Antagonists
Physiological Effects of Drugs processed this record on August 18, 2017